UBS Group’s BIND THERAPEUTICS INC BIND Stock Holding History

UBS Group’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-37,601	Closed	-$15K	–	8370
2016 Q2	$15K	Buy	37,601 +33,601	+840%	+$27.6K	﹤0.01%	6548
2016 Q1	$9K	Buy	4,000 +1,000	+33%	+$1.81K	﹤0.01%	6760
2015 Q4	$7K	Sell	3,000 -188	-6%	-$760	﹤0.01%	7573
2015 Q3	$14K	Sell	3,188 -3,832	-55%	-$18.8K	﹤0.01%	7051
2015 Q2	$39K	Buy	7,020 +680	+11%	+$4.21K	﹤0.01%	6237
2015 Q1	$35K	Buy	6,340 +2,829	+81%	+$17.4K	﹤0.01%	6418
2014 Q4	$19K	Buy	+3,511	New	+$26.3K	﹤0.01%	7777

UBS Group's BIND Position: Q3 2016 in Review

UBS Group sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 37,601 shares — an estimated $15K sold.

UBS Group first reported a position in BIND in Q4 2014 and held it in 7 quarters. The position peaked at $39K in Q2 2015. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.

UBS Group reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
UBS Group sold 37,601 BIND THERAPEUTICS INC shares in Q3 2016, an estimated $15K.
UBS Group first reported a position in BIND THERAPEUTICS INC in Q4 2014 and held it in 7 quarters.
UBS Group's BIND THERAPEUTICS INC position peaked at $39K in Q2 2015.
0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.